Gene.iO 2023 – 8 award-winning innovative biotechs
October 16, 2023 – 8 innovative biotech companies have just been selected in the 3rd promotion of Genopole's Gene.iO program: they win a year's coaching at the cutting edge of biotech expertise, to help them successfully raise their first funds or sign their first commercial agreement.
16 October 0203
Read the articleGenopole and the COBIOE project consortium open an interconnection platform for the European biomanufacturing sector
The COBIOE project aims to build a shared and inclusive strategy for strengthening and interconnecting Europe's healthcare biomanufacturing sector. A part of the Horizon Europe program's European Innovation Ecosystems theme and coordinated by Genopole, the 24-month project is initiating the first step of its Europe-wide interconnection platform for biomanufacturing professionals.
20 February 2024
Read the articleGenopole is organizing the third edition of the D4Gen Hackathon
On 22–24 March 2024, Genopole will hold its third annual D4Gen Hackathon for innovation in life sciences. Students, researchers and start-uppers will build teams and imagine novel digital solutions to better understand the mechanisms of life and complex systems, to model them and find inspiration therein.
13 February 2024
Read the articleGenopole announces 5 i-Lab startup winners
July 6, 2023 – Five biotech companies from Genopole, a biocluster dedicated to innovation for health and sustainable development, have won the i-Lab national competition run by Bpifrance and the French Ministry of Higher Education, Research and Innovation, to support the most promising deep-tech companies in France.
06 July 2023
Read the articleBiopharmaceuticals Major Challenge: The University of Évry and Genopole present in three of the eight laureate projects
ART-TG, CiTHERA, I-Stem and Yposkesi are contributing their expertise to three projects named on 3 February 2022 as laureates for the French Government's Major Challenges program.
02 March 2022
Read the articleIGEM 2021: Yet another Gold Medal!
19 novembre 2021 – Pour la 5ème année consécutive, l’équipe d’Évry décroche une médaille d’or au célèbre concours international en biologie de synthèse iGEM, grâce à son projet « Evolution T7 » reposant sur l’évolution génétique dirigée et ouvrant un vaste champ d’applications.
19 November 2021
Read the articleAlgentech: High-Yield Molecular Farming Of Industrial Ingredients In Plant Chloroplasts
22 juin 2021 – Algentech, a Genopole-accredited French company, has achieved a world's first with its disruptive technology . The company's patented method enables the production of proteins and nucleic acids in plant chloroplasts.
22 June 2021
Read the articleGenopole earns EU|BIC certification
5 décembre 2020 The European Commission's European Business Network (EBN) voted unanimously to certify Genopole as a European Union | Business and Innovation Center (EU|BIC), thus recognizing France's leading biocluster as a key contributor to R&D and Innovation in Genomics in France and Europe.
5 December 2020
Read the articleEnalees announces clinical trial for a COVID-19 test
16 septembre 2020 – C4Diagnostics, Bertin Technologies and Enalees announced the launch of a prospective clinical trial for BEC-SARS-CoV-2 for humans, a rapid, point-of-care diagnostic for COVID-19.
16 September 2020
Read the articleŸnsect obtains market approval for an insect-based fertilizer
17 juin 2020 – Ÿnsect has just gained approval for its natural insect fertilizer “ŸnFrass” issued by ANSES, the French Agency for Food, Environmental and Occupational Health & Safety. Ÿnsect thus becomes the first company in the world to obtain certification and marketing approval for a natural insect-based fertilizer.
17 June 2020
Read the articlePharnext – A novel strategy to rapidly reposition drugs using existing COVID-19 clinical data
23 mars 2020 – Pharnext annonce l’identification de 97 médicaments fréquemment prescrits, au moyen de sa plateforme de Pleotherapy, comme candidats potentiels au repositionnement dans le traitement du COVID-19.
23 March 2020
Read the articleA Friendly Takeover Bid Initiated by OncoDNA on IntegraGen
July 09, 2020 This transaction would bring together OncoDNA’s expertise in oncology precision medicine and IntegraGen’s know-how in DNA sequencing services and bioinformatics analyses. The combination of both companies would enable to offer a complete solution that combines oncology laboratory testing and software solutions which will benefit the treatment of patients with advanced cancer.
9 July 2020
Read the articleIntegraGen renews its agreement with the Institut Pasteur
11 mars 2020 – IntegraGen announces the renewal of its partnership agreement with the Institut Pasteur until December 2021 related to high-throughput sequencing operations for microbiology activities carried out at the Institut Pasteur
11 March 2020
Read the articleAB Science : masitinib’s potential mode of action in Alzheimer’s Disease
July 08, 2020 – AB Science SA announced the publication of preclinical study results with masitinib in Alzheimer’s disease entitled, ‘Effects of chronic masitinib treatment in APPPS1dE9 transgenic mice modeling Alzheimer’s disease’.
8 July 2020
Read the articleAlgentech Granted US Patent For A Key Genome Editing Technology
16 janvier 2020- Algentech annonce la délivrance d'un brevet clé dans le domaine de l'édition du génome par l'Office des brevets des États-Unis
16 January 2020
Read the article